226 related articles for article (PubMed ID: 17457095)
1. Trends in HIV prevalence in blood donations in Europe, 1990-2004.
Likatavicius G; Hamers FF; Downs AM; Alix J; Nardone A
AIDS; 2007 May; 21(8):1011-8. PubMed ID: 17457095
[TBL] [Abstract][Full Text] [Related]
2. Retrospective surveillance of HIV prevalence in blood donors can help in the selection of the best social group for blood donation in Mali.
Tounkara A; Diakite M; Noumsi GT; Sarro YD; Siddiqui S; Parta M
Transfus Med; 2009 Oct; 19(5):252-9. PubMed ID: 19747288
[TBL] [Abstract][Full Text] [Related]
3. Prevalence, incidence, and residual risk of human immunodeficiency virus among community and replacement first-time blood donors in São Paulo, Brazil.
Barreto CC; Sabino EC; Gonçalez TT; Laycock ME; Pappalardo BL; Salles NA; Wright DJ; Chamone DF; Busch MP
Transfusion; 2005 Nov; 45(11):1709-14. PubMed ID: 16271094
[TBL] [Abstract][Full Text] [Related]
4. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
5. Correlates of HIV infection among former blood/plasma donors in rural China.
Ji G; Detels R; Wu Z; Yin Y
AIDS; 2006 Feb; 20(4):585-91. PubMed ID: 16470123
[TBL] [Abstract][Full Text] [Related]
6. Human immunodeficiency virus prevalence, incidence, and residual transmission risk in first-time and repeat blood donations in Zimbabwe: implications on blood safety.
Mapako T; Mvere DA; Chitiyo ME; Rusakaniko S; Postma MJ; van Hulst M
Transfusion; 2013 Oct; 53(10 Pt 2):2413-21. PubMed ID: 23789991
[TBL] [Abstract][Full Text] [Related]
7. Blood safety: improvements needed in Thailand.
AIDS Wkly Plus; 1996 Oct 7-14; ():16. PubMed ID: 12291667
[TBL] [Abstract][Full Text] [Related]
8. Human immunodeficiency virus type 1 incidence among blood donors in France, 1992 through 2006: use of an immunoassay to identify recent infections.
Pillonel J; Barin F; Laperche S; Bernillon P; Le Vu S; Brunet S; Thierry D; Desenclos JC;
Transfusion; 2008 Aug; 48(8):1567-75. PubMed ID: 18482193
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology of human immunodeficiency virus infection in blood donations in Europe and Italy.
Suligoi B; Raimondo M; Regine V; Salfa MC; Camoni L
Blood Transfus; 2010 Jul; 8(3):178-85. PubMed ID: 20671878
[TBL] [Abstract][Full Text] [Related]
10. An increase in newly diagnosed HIV cases reported among men who have sex with men in Europe, 2000-6: implications for a European public health strategy.
Likatavicius G; Klavs I; Devaux I; Alix J; Nardone A
Sex Transm Infect; 2008 Nov; 84(6):499-505. PubMed ID: 19028955
[TBL] [Abstract][Full Text] [Related]
11. Prevalence of HIV infection in school based and other young donors during the 2002 and 2003 period.
Mandisodza AR; Charuma H; Masoha A; Musekiwa Z; Mvere D; Abayomi A
Afr J Med Med Sci; 2006 Mar; 35(1):69-72. PubMed ID: 17209330
[TBL] [Abstract][Full Text] [Related]
12. HIV/hepatitis coinfection in eastern Europe and new pan-European approaches to hepatitis prevention and management.
Lazarus JV; Shete PB; Eramova I; Merkinaite S; Matic S
Int J Drug Policy; 2007 Oct; 18(5):426-32. PubMed ID: 17854732
[TBL] [Abstract][Full Text] [Related]
13. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
14. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of HIV-1 in blood donations following implementation of a structured blood safety policy in South Africa.
Heyns Adu P; Benjamin RJ; Swanevelder JP; Laycock ME; Pappalardo BL; Crookes RL; Wright DJ; Busch MP
JAMA; 2006 Feb; 295(5):519-26. PubMed ID: 16449617
[TBL] [Abstract][Full Text] [Related]
16. Epidemiology of hepatitis B in Canadian blood donors.
O'Brien SF; Xi G; Fan W; Yi QL; Fearon MA; Scalia V; Goldman M
Transfusion; 2008 Nov; 48(11):2323-30. PubMed ID: 18647366
[TBL] [Abstract][Full Text] [Related]
17. [Recent data on HIV epidemiology in Germany].
Glück D; Kubanek B
Beitr Infusionsther; 1993; 31():1-4. PubMed ID: 7693233
[TBL] [Abstract][Full Text] [Related]
18. Cost-effectiveness of HIV screening of blood donations in Accra (Ghana).
van Hulst M; Sagoe KW; Vermande JE; van der Schaaf IP; van der Tuuk Adriani WP; Torpey K; Ansah J; Mingle JA; Smit Sibinga CT; Postma MJ
Value Health; 2008; 11(5):809-19. PubMed ID: 18489518
[TBL] [Abstract][Full Text] [Related]
19. Autologous blood donor screening indicated a lower prevalence of viral hepatitis in East vs West Germany: epidemiological benefit from established health resources.
Wiegand J; Luz B; Mengelkamp AK; Moog R; Koscielny J; Halm-Heinrich I; Susemihl C; Bentzien F; Diekmann J; Wernet D; Karger R; Angert K; Schmitt-Thomssen A; Kiefel V; Lutter K; Hesse R; Kätzel R; Opitz A; Luhm J; Barz D; Leib U; Matthes G; Tillmann HL
J Viral Hepat; 2009 Oct; 16(10):743-8. PubMed ID: 19486277
[TBL] [Abstract][Full Text] [Related]
20. A method for estimating incidence rate of infectious diseases among first-time blood donors.
Zou S; Fang CT; Dodd RY
Transfusion; 2008 Sep; 48(9):1827-32. PubMed ID: 18482184
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
